Slovakia - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

zentiva, k.s., Česká republika - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica

Slovakia - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

glenmark pharmaceuticals s.r.o., Česká republika - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica

Slovakia - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

glenmark pharmaceuticals s.r.o., Česká republika - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica

Slovakia - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

glenmark pharmaceuticals s.r.o., Česká republika - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica

Slovakia - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

zentiva k.s., Česká republika - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica

Slovakia - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

zentiva k.s., Česká republika - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica

Slovakia - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

elc group s.r.o., Česká republika - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica

Slovakia - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

elc group s.r.o., Česká republika - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica

Den europeiske union - litauisk - EMA (European Medicines Agency)

teva b.v. - salmeterol, fluticasone propionatas - pulmonary disease, chronic obstructive; asthma - vaistai nuo obstrukcinių kvėpavimo takų ligų, - airexar spiromax skirtas vartoti tik suaugusiesiems nuo 18 metų ir vyresnių. asthmaairexar spiromax is indicated for the regular treatment of patients with severe asthma where use of a combination product (inhaled corticosteroid and long-acting β2 agonist) is appropriate:- patients not adequately controlled on a lower strength corticosteroid combination productor- patients already controlled on a high dose inhaled corticosteroid and long-acting β2 agonist. lėtinė obstrukcinė plaučių liga (lopl)airexar spiromax fluorouracilu ir simptominis gydymas pacientams, sergantiems lopl, su fev1.

Den europeiske union - islandsk - EMA (European Medicines Agency)

teva b.v. - salmeterol, flútikasón nef - pulmonary disease, chronic obstructive; asthma - lyf til veikindi öndunarvegi sjúkdómum, - airexar spiromax er ætlað til notkunar hjá fullorðnum 18 ára og eldri. asthmaairexar spiromax is indicated for the regular treatment of patients with severe asthma where use of a combination product (inhaled corticosteroid and long-acting β2 agonist) is appropriate:- patients not adequately controlled on a lower strength corticosteroid combination productor- patients already controlled on a high dose inhaled corticosteroid and long-acting β2 agonist. langvinn veikindi í lungum (llt)airexar viðeigandi er ætlað til meðferð við sjúklinga með llt, með fev1.